EIF4A3 and intrahepatic cholangiocarcinoma: The combined intervention of EIF4A3 and circPCSK6 highlights a promising avenue for comprehensive ICC treatment, where targeting EIF4A3 may enhance circPCSK6‐mediated anticarcinogenic effects, thus increasing treatment efficacy.